QuickView for positive regulation of microtubule plus-end binding (biogroup)

1. L1000 CMAP - Breast cancer HS578T cells treated with ligand perturbagens
2. L1000 CMAP Breast cancer MCF7 cells with gene overexpression perturbations
3. L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (1 of 2)
4. L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
5. Drug Matrix In Vivo Toxicogenomic Study - Rat Bone Marrow [Codelink]

There were no matches for positive regulation of microtubule plus-end binding

1. NeoPHOEBE: Neoadjuvant Trastuzumab + BKM120 in Combination With Weekly Paclitaxel in HER2-positive P…